Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Pivotal Study of RenewTM NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Dementia of the Alzheimer's Type

NCT03721705 is registered in ClinicalTrials.gov with Renew Research, LLC as lead sponsor.

NCT NCT03721705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03721705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Pivotal Study of RenewTM NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Dementia of the Alzheimer's Type
Lead sponsor
Renew Research, LLC
Phase
Phase 3
Overall status
Completed
Start date
November 12, 2018
Completion date
March 23, 2021
Enrollment
190 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive decline, cognitive dysfunction, dementia, alzheimer type, mild cognitive impairment, mild dementia